These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15136055)

  • 1. Inhibitory efficacy of pitavastatin on the early inflammatory response and neointimal thickening in a porcine coronary after stenting.
    Yokoyama T; Miyauchi K; Kurata T; Satoh H; Daida H
    Atherosclerosis; 2004 Jun; 174(2):253-9. PubMed ID: 15136055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pioglitazone attenuates neointimal thickening via suppression of the early inflammatory response in a porcine coronary after stenting.
    Kasai T; Miyauchi K; Yokoyama T; Kajimoto K; Sumiyoshi K; Kubota N; Ikeda E; Daida H
    Atherosclerosis; 2008 Apr; 197(2):612-9. PubMed ID: 17950297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of statin-eluting stent on early inflammatory response and neointimal thickness in a porcine coronary model.
    Miyauchi K; Kasai T; Yokayama T; Aihara K; Kurata T; Kajimoto K; Okazaki S; Ishiyama H; Daida H
    Circ J; 2008 May; 72(5):832-8. PubMed ID: 18441467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-arginine supplementation does not inhibit neointimal formation after coronary stenting in human beings: an intravascular ultrasound study.
    Dudek D; Legutko J; Heba G; Bartus S; Partyka L; Huk I; Dembinska-Kiec A; Kaluza GL; Dubiel JS
    Am Heart J; 2004 Apr; 147(4):E12. PubMed ID: 15077095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local methylprednisolone delivery using a BiodivYsio phosphorylcholine-coated drug-delivery stent reduces inflammation and neointimal hyperplasia in a porcine coronary stent model.
    Huang Y; Liu X; Wang L; Verbeken E; Li S; De Scheerder I
    Int J Cardiovasc Intervent; 2003; 5(3):166-71. PubMed ID: 12959735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of probucol on neointimal thickening in a stent porcine restenosis model.
    Yokoyama T; Miyauchi K; Kurata T; Sato H; Daida H
    Jpn Heart J; 2004 Mar; 45(2):305-13. PubMed ID: 15090707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of a tacrolimus-eluting stent to inhibit neointimal hyperplasia in a porcine coronary model.
    Huang Y; Salu K; Wang L; Liu X; Li S; Lorenz G; Wnendt S; Verbeken E; Bosmans J; Van de Werf F; De Scheerder I
    J Invasive Cardiol; 2005 Mar; 17(3):142-8. PubMed ID: 15867441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The efficacy of tetramethylpyrazine-eluting stents on inhibiting neointima formation in porcine coronary arteries].
    Chen LJ; Feng Y; Ding S
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Sep; 36(9):843-6. PubMed ID: 19102872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary artery overexpansion increases neointimal hyperplasia after stent placement in a porcine model.
    Russo RJ; Silva PD; Yeager M
    Heart; 2007 Dec; 93(12):1609-15. PubMed ID: 17639098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zotarolimus-eluting stents reduce experimental coronary artery neointimal hyperplasia after 4 weeks.
    Garcia-Touchard A; Burke SE; Toner JL; Cromack K; Schwartz RS
    Eur Heart J; 2006 Apr; 27(8):988-93. PubMed ID: 16449248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetramethylpyrazine-eluting stents prevented in-stent restenosis in a porcine model.
    Ma G; Ding S; Feng Y; Shen C; Chen L; Chen Z
    J Cardiovasc Pharmacol; 2007 Aug; 50(2):201-5. PubMed ID: 17703137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective ET(A) receptor antagonism reduces neointimal hyperplasia in a porcine coronary stent model.
    McKenna CJ; Burke SE; Opgenorth TJ; Padley RJ; Camrud LJ; Camrud AR; Johnson J; Carlson PJ; Lerman A; Holmes DR; Schwartz RS
    Circulation; 1998 Jun; 97(25):2551-6. PubMed ID: 9657476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pioglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with type 2 diabetes mellitus: an intravascular ultrasound scanning study.
    Takagi T; Yamamuro A; Tamita K; Yamabe K; Katayama M; Mizoguchi S; Ibuki M; Tani T; Tanabe K; Nagai K; Shiratori K; Morioka S; Yoshikawa J
    Am Heart J; 2003 Aug; 146(2):E5. PubMed ID: 12891212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind, randomized, placebo-controlled multicenter clinical trial to evaluate the effects of the angiotensin II receptor blocker candesartan cilexetil on intimal hyperplasia after coronary stent implantation.
    Radke PW; Figulla HR; Drexler H; Klues HG; Mügge A; Silber S; Daniel W; Schmeisser A; Reifart N; Motz W; Büttner HJ; Fischer D; Ortlepp JR; Schaefers K; Hoffmann R; Hanrath P;
    Am Heart J; 2006 Oct; 152(4):761.e1-6. PubMed ID: 16996855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Genous™ endothelial progenitor cell capture stent accelerates stent re-endothelialization but does not affect intimal hyperplasia in porcine coronary arteries.
    van Beusekom HM; Ertaş G; Sorop O; Serruys PW; van der Giessen WJ
    Catheter Cardiovasc Interv; 2012 Feb; 79(2):231-42. PubMed ID: 21834062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paradoxical effects of aurintricarboxylic acid and RG-13577: acute thrombosis and in-stent stenosis in a passive-coated stent.
    Strehblow C; Sperker W; Hevesi A; Garamvölgyi R; Petrasi Z; Shirazi M; Sylvén C; Weiss T; Lotan C; Pugatsch T; Ben-Sasson SA; Orlowski M; Glogar D; Gyöngyösi M
    J Endovasc Ther; 2006 Feb; 13(1):94-103. PubMed ID: 16445329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental efficacy of an everolimus eluting cobalt chromium stent.
    Carter AJ; Brodeur A; Collingwood R; Ross S; Gibson L; Wang CA; Haller S; Coleman L; Virmani R
    Catheter Cardiovasc Interv; 2006 Jul; 68(1):97-103. PubMed ID: 16755598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of neointimal hyperplasia after coronary stenting by pioglitazone in nondiabetic patients with metabolic syndrome.
    Katayama T; Ueba H; Tsuboi K; Kubo N; Yasu T; Kuroki M; Saito M; Momomura S; Kawakami M
    Am Heart J; 2007 May; 153(5):762.e1-7. PubMed ID: 17452150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct stenting limits sirolimus-eluting stent edge neointimal thickening.
    Guérin P; Gouëffic Y; Heymann MF; Pillet P; Al Habash O; Crochet D; Pacaud P; Loirand G
    J Vasc Surg; 2007 Aug; 46(2):354-9. PubMed ID: 17664110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous subcutaneous angiopeptin treatment significantly reduces neointimal hyperplasia in a porcine coronary in-stent restenosis model.
    Hong MK; Kent KM; Mehran R; Mintz GS; Tio FO; Foegh M; Wong SC; Cathapermal SS; Leon MB
    Circulation; 1997 Jan; 95(2):449-54. PubMed ID: 9008463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.